The selection and use of essential medicines
report of the WHO Expert Committee, 2011 (including the 17th WHO Model List of Essential Medicines and the 3rd WHO Model List of Essential Medicines for Children)
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 508208483 | ||
| 003 | CHVBK | ||
| 005 | 20201001101415.0 | ||
| 008 | 180302s2012 sz ||||i100 |eng|d | ||
| 020 | |a 978-92-4-120965-6 | ||
| 020 | |a 92-4-120965-8 | ||
| 035 | |a (NEBIS)011131557 | ||
| 035 | |a (SNL)991017624529703976 | ||
| 035 | |a (OCoLC)808811919 | ||
| 035 | |a (Sz)1691401-41snl_51 | ||
| 035 | |a (Sz)vtls001691401 | ||
| 035 | |a (Sz)001691401 | ||
| 040 | |a NUI |b eng |d SzZuIDS NEBIS ETH-BIB |e rda | ||
| 050 | 1 | |a RA8 |b .A25 no. 965 | |
| 082 | 7 | 4 | |a 610 |2 23sdnb |
| 110 | 2 | |a Weltgesundheitsorganisation |b Expert Committee on the Selection and Use of Essential Medicines |0 (DE-588)5552869-7 |e Verfasser |4 aut | |
| 245 | 1 | 4 | |a The selection and use of essential medicines |b report of the WHO Expert Committee, 2011 (including the 17th WHO Model List of Essential Medicines and the 3rd WHO Model List of Essential Medicines for Children) |
| 246 | 1 | 3 | |a 17th WHO Model List of Essential Medicines |
| 246 | 1 | 3 | |a Seventeenth WHO Model List of Essential Medicines |
| 246 | 1 | 3 | |a 3rd WHO Model List of Essential Medicines for Children |
| 246 | 1 | 3 | |a Third WHO Model List of Essential Medicines for Children |
| 264 | 1 | |a Geneva |b World Health Organization |c [2012] | |
| 300 | |a xiv, 249 pages | ||
| 490 | 1 | |a WHO technical report series |v 965 |i 965 |w (NEBIS)000023541 |9 278782957 | |
| 500 | |a The 18th Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicine took place in Accra, Ghana on 21-25 March 2011 | ||
| 504 | |a Includes bibliographical references (pages 227-249) | ||
| 650 | 0 | |a Drugs |x Standards |v Congresses | |
| 650 | 0 | |a Medicine |v Formulae, receipts, prescriptions |v Congresses | |
| 650 | 0 | |a Drug utilization |x Standards |v Congresses | |
| 650 | 2 | |a Drugs, Essential |x administration & dosage |0 (DNLM)D018954Q000008 | |
| 650 | 2 | |a Drug Information Services |0 (DNLM)D004346 | |
| 650 | 2 | |a Drug Utilization |x standards |0 (DNLM)D004363Q000592 | |
| 650 | 2 | |a Formularies as Topic |0 (DNLM)D005569 | |
| 650 | 2 | |a Pharmaceutical Preparations |x standards |0 (DNLM)D004364Q000592 | |
| 650 | 7 | |a ARZNEIMITTELGLIEDERUNG NACH IHRER HAUPTWIRKUNG |x ger |0 (ETHUDK)000026663 |2 ethudk | |
| 650 | 7 | |a ARZNEIMITTELVERABREICHUNG + ARZNEIMITTELANWENDUNGSFORMEN (PHARMAKOLOGIE) |x ger |0 (ETHUDK)000026638 |2 ethudk | |
| 650 | 7 | |a DOSIS-WIRKUNG BEZIEHUNG UND DOSIMETRIE (PHARMAKOLOGIE) |x ger |0 (ETHUDK)000026628 |2 ethudk | |
| 650 | 7 | |a LISTEN, AUFSTELLUNGEN IM ALLGEMEINEN (DOKUMENTENTYP) |x ger |0 (ETHUDK)000000109 |2 ethudk | |
| 655 | 7 | |a Konferenzschrift |z Accra |y 2011 |2 gnd-content | |
| 691 | 7 | |B u |a ARZNEIMITTELGLIEDERUNG NACH IHRER HAUPTWIRKUNG |z ger |u 615.2 |2 nebis E1 | |
| 691 | 7 | |B u |a ARZNEIMITTELVERABREICHUNG + ARZNEIMITTELANWENDUNGSFORMEN (PHARMAKOLOGIE) |z ger |u 615.032 |2 nebis E1 | |
| 691 | 7 | |B u |a DOSIS-WIRKUNG BEZIEHUNG UND DOSIMETRIE (PHARMAKOLOGIE) |z ger |u 615.015.3 |2 nebis E1 | |
| 691 | 7 | |B u |a LISTEN, AUFSTELLUNGEN IM ALLGEMEINEN (DOKUMENTENTYP) |z ger |u (083.81) |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMACEUTICAL DRUG CLASSIFICATION ACCORDING TO MAIN EFFECTS |z eng |u 615.2 |2 nebis E1 | |
| 691 | 7 | |B u |a CLASSIFICATION DES MÉDICAMENTS SELON LES EFFETS MAJEURS |z fre |u 615.2 |2 nebis E1 | |
| 691 | 7 | |B u |a DRUG ADMINISTRATION + TYPES OF DRUG ADMINISTRATION (PHARMACOLOGY) |z eng |u 615.032 |2 nebis E1 | |
| 691 | 7 | |B u |a APPLICATIONS DE MÉDICAMENTS + FORMES D'APPLICATION DES MÉDICAMENTS (PHARMACOLOGIE) |z fre |u 615.032 |2 nebis E1 | |
| 691 | 7 | |B u |a DOSAGE + RELATION ENTRE DOSAGE ET ACTION DES MÉDICAMENTS (PHARMACOLOGIE) |z fre |u 615.015.3 |2 nebis E1 | |
| 691 | 7 | |B u |a DOSISMETRY + DOSE RESPONSE + DOSAGE (PHARMACOLOGY) |z eng |u 615.015.3 |2 nebis E1 | |
| 691 | 7 | |B u |a LISTS, SCHEDULES IN GENERAL (DOCUMENT TYPE) |z eng |u (083.81) |2 nebis E1 | |
| 691 | 7 | |B u |a LISTES EN GÉNÉRAL (TYPE DE DOCUMENT) |z fre |u (083.81) |2 nebis E1 | |
| 691 | 7 | |a sb |b 2012/22 |c 610 |k ge |2 snl-sb | |
| 830 | 0 | |a Technical report series |g Weltgesundheitsorganisation |v 965 |7 (Sz)000067788 | |
| 898 | |a BK020800 |b XK020000 |c XK020000 | ||
| 912 | 7 | |a 134 |2 E01 | |
| 949 | |B SNL |F NB001 |b NB001 |j N 323870 |c NB10010 | ||
| 950 | |B NEBIS |P 110 |E 2- |a Weltgesundheitsorganisation |b Expert Committee on the Selection and Use of Essential Medicines |0 (DE-588)5552869-7 |e Verfasser |4 aut | ||
| 950 | |B NEBIS |P 490 |E 0- |a WHO technical report series |v 965 |i 965 |w (NEBIS)000023541 |9 278782957 | ||
| 950 | |B SNL |P 110 |E 2- |a WHO Expert Committee on the Selection and Use of Essential Medicines |b Meeting |n (18 |d 2011 |c Accra, Ghana) | ||
| 950 | |B SNL |P 490 |E 1- |a WHO technical report series |x 0512-3054 |v 965 | ||
| 950 | |B SNL |P 710 |E 2- |a Weltgesundheitsorganisation |0 (DE-588)1007857-5 | ||
| 950 | |B SNL |P 711 |E 2- |a Kongress |d (2011 |c Accra, Ghana) | ||
| 950 | |B SNL |P 830 |E -- |a Technical report series |g Weltgesundheitsorganisation |v 965 |7 (Sz)000067788 | ||
| 950 | |B SNL |P 856 |E 41 |u https://opac.admin.ch/toc/toc001691401.pdf |y Inhaltsverzeichnis | ||
| 956 | 4 | |B NEBIS |C EAD50 |u https://opac.nebis.ch/objects/pdf03/e16_978-92-4-120965-6_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |
| 986 | |a SWISSBIB |b 507627873 | ||